Pharmaceutical uses and synthesis of nicotinamides
    2.
    发明授权
    Pharmaceutical uses and synthesis of nicotinamides 失效
    制药用途和合成烟酰胺

    公开(公告)号:US06777432B1

    公开(公告)日:2004-08-17

    申请号:US10237258

    申请日:2002-09-04

    IPC分类号: A61K3144

    摘要: A compound of the formula and pharmaceutically acceptable salts thereof, wherein R1 is selected from (R3)C(═O)—N(R4)— and (R3)(R4)N—C(═O)—; R2 is selected from —OR5 and —N(R5)(R6); n is 0, 1, 2 or 3; X is selected from oxygen and sulfur; and R3, R4, R5 and R6 are independently selected from hydrogen, alkyl, heteroalkyl, aryl, aryl(akylene), heteroaryl, heteroaryl(alkylene), carbocycle, carbocycle(alkylene), heterocycle, and heterocycle(alkylene); as well as pharmaceutical compositions containing said compound. The compounds and compositions are useful in, for example, the treatment of inflammatory events in an animal subject.

    摘要翻译: 式(I)化合物及其药学上可接受的盐,其中R 1选自(R 3)C(= O)-N(R 4) - 和(R 3)(R 4) = O) - ; R 2选自-OR 5和-N(R 5)(R 6); n为0,1,2或3; X选自氧和硫; 并且R 3,R 4,R 5和R 6独立地选自氢,烷基,杂烷基,芳基,芳基(亚烷基),杂芳基,杂芳基(亚烷基),碳环,碳环(亚烷基) ,杂环和杂环(亚烷基); 以及含有所述化合物的药物组合物。 化合物和组合物可用于例如在动物受试者中治疗炎性事件。